# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: George H. W. Bush (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML018-SYN-TD
- Date: 1991-07-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Douglas Whitford, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Seven-week review after radioactive iodine. **S**

## History of present illness

Mr. Bush returns seven weeks after radioactive iodine. He stopped methimazole three days before the treatment and has not restarted it. For about two weeks he has felt more tired in the afternoons, a little cold in air-conditioned rooms, and slightly constipated, and he has regained 2.2 kg. He has had no palpitations, and his home pulse checks have been regular. He takes metoprolol and apixaban every day, with no bleeding. He has started running again, two miles three days a week, without symptoms. He has no neck pain, eye symptoms, or swallowing trouble. He knows of no snoring and has no daytime sleepiness. **S**

| Element | Detail |
|---|---|
| Since radioactive iodine | Tiredness, mild cold intolerance, and constipation for about two weeks; weight up 2.2 kg |
| Rhythm | No palpitations; regular pulse on home checks |
| Apixaban safety | No bleeding; no missed doses |
| Activity | Running two miles three days a week |
| Sleep | No snoring or daytime sleepiness |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Afternoon tiredness and mild cold intolerance; weight up 2.2 kg |
| Gastrointestinal | Positive | Mild constipation |
| Cardiovascular | Negative | No palpitations, chest pain, or lightheadedness |
| Eyes | Negative | No grittiness, pain, or double vision |

4 systems reviewed. **S**

## Current medications

- Metoprolol succinate extended-release 25 mg oral tablet, one tablet by mouth daily (taper) **S**
- Apixaban 5 mg oral tablet, one tablet by mouth twice daily (started in hospital) **S**
- Levothyroxine 75 mcg oral tablet, one tablet by mouth daily before breakfast **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/76 mmHg; pulse 64 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 88.6 kg; BMI 25.1 kg/m². All vital signs are synthetic.

TSH: 5.6 mIU/L (high); Free T4: 0.6 ng/dL (low); Total T3: 78 ng/dL (low). All results are synthetic.

## Change since baseline

- TSH: 0.005 mIU/L (low) at baseline, 5.6 mIU/L (high) at this visit **S**
- Free T4: 3.6 ng/dL (high) at baseline, 0.6 ng/dL (low) at this visit **S**
- Total T3: 280 ng/dL (high) at baseline, 78 ng/dL (low) at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; calm |
| Eyes | No lid retraction or proptosis |
| Neck | Thyroid smaller and non-tender |
| Cardiovascular | Regular rhythm at 64 per minute |
| Neurological | No tremor; ankle reflexes slightly slow to relax |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hypothyroidism after radioactive iodine** (E89.0). Free T4 0.6 ng/dL and total T3 78 ng/dL are low, with TSH rising to 5.6 mIU/L, and he has early hypothyroid symptoms: the expected result of radioactive iodine for Graves' disease. **S**
   - Start levothyroxine 75 mcg daily on an empty stomach, below full replacement because of his age and recent atrial fibrillation.
   - TSH and free T4 in eight weeks.
2. **Graves' disease treated with radioactive iodine** (E05.00). No longer thyrotoxic; no eye disease. **S**
   - Eye symptoms to be reported promptly; eye examination at the yearly review.
3. **Paroxysmal atrial fibrillation, in sinus rhythm** (I48.0). Sinus rhythm with a resting rate of 64 now that he is no longer thyrotoxic. Sleep apnea screen negative (STOP-BANG 2). **S**
   - Reduce metoprolol succinate to 25 mg daily for eight weeks, then stop.
   - Continue apixaban for now; wear a 14-day ECG patch in about five weeks, once thyroid levels are closer to normal, and decide about apixaban at the next visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Heart rate and rhythm | Every visit | Completed today | 64 per minute, regular |
| Examination | Blood pressure | Every visit; target below 130/80 | Completed today | 128/76 mmHg |
| Examination | Weight and BMI | Every visit | Completed today | 88.6 kg, BMI 25.1; up 2.2 kg |
| Survey | Atrial fibrillation symptoms | Every visit | Completed today | None |
| Imaging | Ambulatory rhythm monitoring | As symptoms or decisions require | Ordered | 14-day ECG patch in about five weeks, to confirm sinus rhythm before the anticoagulation decision |
| Medication safety | Anticoagulant adherence and bleeding | Every visit | Completed today | No missed doses; no bleeding |
| Survey | CHA2DS2-VASc and HAS-BLED | Yearly and with any change in clinical status | Up to date | Unchanged: CHA2DS2-VASc 1, HAS-BLED 1 |
| Self-management | Alcohol, tobacco, and physical activity | Every visit | Completed today | No alcohol; never used tobacco; running two miles three days a week |
| Survey | Sleep apnea symptom screen | At diagnosis and at least yearly | Completed today | STOP-BANG 2: low risk; no sleep study needed. Completed two months late; no harm resulted, as the screen is negative. Corrective action: the screen is now on the atrial fibrillation intake checklist |
| Laboratory | Free T4 and total T3 after radioactive iodine | Within one to two months of treatment, then every four to six weeks until stable | Completed today | Free T4 0.6 ng/dL and total T3 78 ng/dL, both low; TSH 5.6 mIU/L |
| Survey | Hypothyroid and overtreatment symptoms | Every visit during titration | Completed today | Tiredness, cold intolerance, and constipation; no palpitations or tremor |
| Laboratory | TSH after starting levothyroxine | Four to eight weeks after each dose change | Due | Due in eight weeks |
| Medication safety | Levothyroxine timing and interactions | At the start of treatment and with new medicines | Completed today | Taken alone on an empty stomach; no calcium, iron, or acid-suppressing medicine |

## Goal progress

- Resting heart rate below 110 per minute without palpitations while thyrotoxic. Outcome by 1991-05-20: Heart rate 72 in sinus rhythm on metoprolol two weeks after intake. **S**
- No atrial fibrillation once no longer thyrotoxic, confirmed by ambulatory monitoring before the anticoagulation decision. In progress; target 1991-09-11. **S**
- TSH within 0.4 to 4.0 mIU/L on levothyroxine. In progress; target 1991-10-16. **S**
- Back to running three miles several days a week without symptoms. In progress; target 1991-09-11. **S**

## Medication changes

- Stopped: Metoprolol succinate extended-release 50 mg oral tablet, one tablet by mouth daily (started in hospital) **S**
- Started: Metoprolol succinate extended-release 25 mg oral tablet, one tablet by mouth daily (taper) **S**
- Started: Levothyroxine 75 mcg oral tablet, one tablet by mouth daily before breakfast **S**

## Guideline basis

- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (2023), American College of Cardiology, American Heart Association, American College of Chest Physicians, and Heart Rhythm Society (Circulation 2024;149(1):e1-e156)
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016), American Thyroid Association (Thyroid 2016;26(10):1343-1421)
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014), American Thyroid Association (Thyroid 2014;24(12):1670-1751)
- CMID: Clinical Monitoring Intelligence Database, atrial fibrillation and hypothyroidism monographs (2026), Aether Forge

## Follow-up

- Thyroid tests and review in eight weeks, after the 14-day ECG patch. **S**
- Next scheduled visit 1991-09-11: four-month review: levothyroxine titration and anticoagulation decision. **S**
